Apteka Exhibition Russian Health Care Week UFI Approved Event
To main
For exhibitors
For visitors

Merck gets US FDA’s approval for OTC Oxytrol patch


Merck has received FDA approval for an over-the-counter treatment for overactive bladder, Oxytrol for Women, BusinessWeek reports.

Oxytrol has been on the market since 2003. The company licensed the exclusive commercialization rights regarding Oxytrol for Women from Watson Pharmaceuticals, Inc., which is currently known as Actavis, Inc.

Source: pharmvestnik.ru

Back to the list

Invite partners to the exhibition
Facebook Youtube RSS Feed

Contacts Flashback Site map
119002 Moscow, Arbat str., 35, of. 423
Тel: +7 (495) 925-65-61/62
Fax: +7 (499) 248-07-34